Karl G Wagner (Karl Wagner)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 33

Top Venues

Pharmaceutics

AAPS PharmSciTech

Natural product reports

PLoS neglected tropical diseases

University of Bonn

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Bonn May 01 2013

Germany

Professor :: Department of Pharmaceutics

Boehringer Ingelheim Pharma GmbH and Co KG Biberach Jan 01 2006 - Apr 30 2013

Germany

Principal scientist :: Pharmaceutical Research and Development

University of Tübingen Dec 31 2001

Germany

wissenschaftl. Assistent (C1) / young investigator :: Department of Pharmaceutical Technology

Publications

Jonas Lenhart, Florian Pöstges, Karl G Wagner, Dominique Jasmin Lunter
Evaluation of Printability of PVA-Based Tablets from Powder and Assessment of Critical Rheological Parameters. Pharmaceutics 16 (4) (2024)
Jonas Lenhart, Florian Pöstges, Karl G Wagner, Dominique Jasmin Lunter
Evaluation of Printability of PVA-Based Tablets from Powder and Assessment of Critical Rheological Parameters. Pharmaceutics 16 (4) (2024)
Guilherme G Moreira, Stephânia Fleury Taveira, Felipe Terra Martins, Karl G Wagner, Ricardo Neves Marreto
Multivariate Analysis of Solubility Parameters for Drug-Polymer Miscibility Assessment in Preparing Raloxifene Hydrochloride Amorphous Solid Dispersions. AAPS PharmSciTech 25 (5) (2024)
Tim Becker, Jan Heitkötter, Anna K Krome, Andrea Schiefer, Kenneth M Pfarr, Alexandra Ehrens, Miriam Grosse, Birthe Sandargo, Ingo Stammberger, Marc Stadler, Marc P Hübner, Stefan Kehraus, Achim Hoerauf, Karl G Wagner
Mesoporous Silica as an Alternative Vehicle to Overcome Solubility Limitations. Pharmaceutics 16 (3) (2024)
Tim Becker, Jan Heitkötter, Anna K Krome, Andrea Schiefer, Kenneth M Pfarr, Alexandra Ehrens, Miriam Grosse, Birthe Sandargo, Ingo Stammberger, Marc Stadler, Marc P Hübner, Stefan Kehraus, Achim Hoerauf, Karl G Wagner
Mesoporous Silica as an Alternative Vehicle to Overcome Solubility Limitations. Pharmaceutics 16 (3) (2024)
Tim Becker, Jan Heitkötter, Anna K Krome, Andrea Schiefer, Kenneth M Pfarr, Alexandra Ehrens, Miriam Grosse, Birthe Sandargo, Ingo Stammberger, Marc Stadler, Marc P Hübner, Stefan Kehraus, Achim Hoerauf, Karl G Wagner
Mesoporous Silica as an Alternative Vehicle to Overcome Solubility Limitations. Pharmaceutics 16 (3) (2024)
Marius Neuwirth, Sebastian K Kappes, Michael U Hartig, Karl G Wagner
Amorphous Solid Dispersions Layered onto Pellets-An Alternative to Spray Drying? Pharmaceutics 15 (3) (2023)
Katharina Dauer, Karl G Wagner
Micro-Scale Vacuum Compression Molding as a Predictive Screening Tool of Protein Integrity for Potential Hot-Melt Extrusion Processes. Pharmaceutics 15 (3) (2023)
Katharina Dauer, Karl G Wagner
Micro-Scale Vacuum Compression Molding as a Predictive Screening Tool of Protein Integrity for Potential Hot-Melt Extrusion Processes. Pharmaceutics 15 (3) (2023)
Katharina Dauer, Karl G Wagner
Micro-Scale Vacuum Compression Molding as a Predictive Screening Tool of Protein Integrity for Potential Hot-Melt Extrusion Processes. Pharmaceutics 15 (3) (2023)
Alexander Denninger, Tim Becker, Ulrich Westedt, Karl G Wagner
Advanced In Vivo Prediction by Introducing Biphasic Dissolution Data into PBPK Models. Pharmaceutics 15 (7) (2023)
Marius Neuwirth, Sebastian K Kappes, Michael U Hartig, Karl G Wagner
Amorphous Solid Dispersions Layered onto Pellets-An Alternative to Spray Drying? Pharmaceutics 15 (3) (2023)
Florian Pöstges, Kevin Kayser, Jan Appelhaus, Marius Monschke, Michael Gütschow, Christian Steinebach, Karl G Wagner
Solubility Enhanced Formulation Approaches to Overcome Oral Delivery Obstacles of PROTACs. Pharmaceutics 15 (1) (2023)
Marvin Benedikt Brenner, Sandra Flory, Matthias Wüst, Theresia Jumbe, Karl G Wagner
Novel Biphasic In Vitro Dissolution Method Correctly Predicts the Oral Bioavailability of Curcumin in Humans. Journal of agricultural and food chemistry (2023)
Florian Pöstges, Kevin Kayser, Jan Appelhaus, Marius Monschke, Michael Gütschow, Christian Steinebach, Karl G Wagner
Solubility Enhanced Formulation Approaches to Overcome Oral Delivery Obstacles of PROTACs. Pharmaceutics 15 (1) (2023)
Florian Pöstges, Kevin Kayser, Jan Appelhaus, Marius Monschke, Michael Gütschow, Christian Steinebach, Karl G Wagner
Solubility Enhanced Formulation Approaches to Overcome Oral Delivery Obstacles of PROTACs. Pharmaceutics 15 (1) (2023)
Florian Pöstges, Kevin Kayser, Jan Appelhaus, Marius Monschke, Michael Gütschow, Christian Steinebach, Karl G Wagner
Solubility Enhanced Formulation Approaches to Overcome Oral Delivery Obstacles of PROTACs. Pharmaceutics 15 (1) (2023)
Marius Neuwirth, Sebastian K Kappes, Michael U Hartig, Karl G Wagner
Amorphous Solid Dispersions Layered onto Pellets-An Alternative to Spray Drying? Pharmaceutics 15 (3) (2023)
Katharina Rox, Tim Becker, Andrea Schiefer, Miriam Grosse, Alexandra Ehrens, Rolf Jansen, Tilman Aden, Stefan Kehraus, Gabriele M König, Anna K Krome, Marc P Hübner, Karl G Wagner, Marc Stadler, Kenneth M Pfarr, Achim Hoerauf
Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant Staphylococcus aureus . Pharmaceutics 15 (1) (2022)
Tim Becker, Anna K Krome, Sahel Vahdati, Andrea Schiefer, Kenneth M Pfarr, Alexandra Ehrens, Tilman Aden, Miriam Grosse, Rolf Jansen, Silke Alt, Thomas Hesterkamp, Marc Stadler, Marc P Hübner, Stefan Kehraus, Gabriele M König, Achim Hoerauf, Karl G Wagner
In Vitro-In Vivo Relationship in Mini-Scale-Enabling Formulations of Corallopyronin A. Pharmaceutics 14 (8) (2022)
Anna K Krome, Tim Becker, Stefan Kehraus, Andrea Schiefer, Michael Gütschow, Lillibeth Chaverra-Muñoz, Stephan Hüttel, Rolf Jansen, Marc Stadler, Alexandra Ehrens, Domen Pogorevc, Daniel Krug, Marc P Hübner, Thomas Hesterkamp, Kenneth M Pfarr, Achim Hoerauf, Karl G Wagner, Gabriele M König
Corallopyronin A: antimicrobial discovery to preclinical development. Natural product reports 39 (9) (2022)
Ann-Cathrin Willmann, Kai Berkenfeld, Thilo Faber, Herbert Wachtel, Georg Boeck, Karl G Wagner
Itraconazole Nanosuspensions via Dual Centrifugation Media Milling: Impact of Formulation and Process Parameters on Particle Size and Solid-State Conversion as Well as Storage Stability. Pharmaceutics 14 (8) (2022)
Katharina Rox, Tim Becker, Andrea Schiefer, Miriam Grosse, Alexandra Ehrens, Rolf Jansen, Tilman Aden, Stefan Kehraus, Gabriele M König, Anna K Krome, Marc P Hübner, Karl G Wagner, Marc Stadler, Kenneth M Pfarr, Achim Hoerauf
Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant Staphylococcus aureus . Pharmaceutics 15 (1) (2022)
Katharina Rox, Tim Becker, Andrea Schiefer, Miriam Grosse, Alexandra Ehrens, Rolf Jansen, Tilman Aden, Stefan Kehraus, Gabriele M König, Anna K Krome, Marc P Hübner, Karl G Wagner, Marc Stadler, Kenneth M Pfarr, Achim Hoerauf
Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant Staphylococcus aureus . Pharmaceutics 15 (1) (2022)
Katharina Rox, Tim Becker, Andrea Schiefer, Miriam Grosse, Alexandra Ehrens, Rolf Jansen, Tilman Aden, Stefan Kehraus, Gabriele M König, Anna K Krome, Marc P Hübner, Karl G Wagner, Marc Stadler, Kenneth M Pfarr, Achim Hoerauf
Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant Staphylococcus aureus . Pharmaceutics 15 (1) (2022)
Barbara V Schönfeld, Ulrich Westedt, Karl G Wagner
Compression Modulus and Apparent Density of Polymeric Excipients during Compression-Impact on Tabletability. Pharmaceutics 14 (5) (2022)
Marius J Kreiser, Christoph Wabel, Karl G Wagner
Impact of Vertical Blender Unit Parameters on Subsequent Process Parameters and Tablet Properties in a Continuous Direct Compression Line. Pharmaceutics 14 (2) (2022)
Katharina Dauer, Stefania Pfeiffer-Marek, Walter Kamm, Karl G Wagner
Microwell Plate-Based Dynamic Light Scattering as a High-Throughput Characterization Tool in Biopharmaceutical Development. Pharmaceutics 13 (2) (2021)
Alexander Denninger, Ulrich Westedt, Karl G Wagner
Shared IVIVR for Five Commercial Enabling Formulations Using the BiPHa+ Biphasic Dissolution Assay. Pharmaceutics 13 (2) (2021)
Marius Monschke, Kevin Kayser, Karl G Wagner
Processing of Polyvinyl Acetate Phthalate in Hot-Melt Extrusion-Preparation of Amorphous Solid Dispersions. Pharmaceutics 12 (4) (2020)
Anna K Krome, Tim Becker, Stefan Kehraus, Andrea Schiefer, Christian Steinebach, Tilman Aden, Stefan J Frohberger, Álvaro López Mármol, Dnyaneshwar Kapote, Rolf Jansen, Lillibeth Chaverra-Muñoz, Marc P Hübner, Kenneth M Pfarr, Thomas Hesterkamp, Marc Stadler, Michael Gütschow, Gabriele M König, Achim Hoerauf, Karl G Wagner
Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A. Pharmaceutics 12 (11) (2020)
Andrea Schiefer, Marc P Hübner, Anna K Krome, Christine Lämmer, Alexandra Ehrens, Tilman Aden, Marianne Koschel, Helene Neufeld, Lillibeth Chaverra-Muñoz, Rolf Jansen, Stefan Kehraus, Gabriele M König, Domen Pogorevc, Daniel Krug, Marc Stadler, Stephan Hüttel, Thomas Hesterkamp, Karl G Wagner, Kenneth M Pfarr, Achim Hoerauf
Corallopyronin A for short-course anti-wolbachial, macrofilaricidal treatment of filarial infections. PLoS neglected tropical diseases 14 (12) (2020)
Marius Monschke, Karl G Wagner
Impact of HPMCAS on the Dissolution Performance of Polyvinyl Alcohol Celecoxib Amorphous Solid Dispersions. Pharmaceutics 12 (6) (2020)

Karl G Wagner.css-eqlu8i{font-size:small;padding-left:4px;} (Karl Wagner)

Publication Activity (10 Years)

Top Topics

Top Venues

Karl G Wagner (Karl Wagner)